Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT Y LIN

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1932244274
CMS profile
269712
Location
GLENDALE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$3,674.02

181 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,674.02 181

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT Y LIN

NPI 1932244274 · CMS profile ID 269712

Allopathic & Osteopathic Physicians / Allergy & Immunology

GLENDALE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932244274?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932244274?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932244274?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 181 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1932244274?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

181 matching records · $3,674.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 181 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 181.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $15.0010/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722837 CMS
GlaxoSmithKline, LLC. $2.7010/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722969 CMS
Incyte Corporation $7.9410/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085643 CMS
Incyte Corporation $4.5210/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085645 CMS
Amgen Inc. $26.9310/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939474269 CMS
CSL Behring $23.4510/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940934121 CMS
OptiNose US, Inc. $22.1309/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928148053 CMS
Regeneron Healthcare Solutions, Inc. $26.0409/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927259717 CMS
ALK-Abello, Inc $16.7109/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905013431 CMS
GlaxoSmithKline, LLC. $17.6809/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722881 CMS
GENZYME CORPORATION $23.9509/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938875277 CMS
Amgen Inc. $21.9609/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939474267 CMS
GlaxoSmithKline, LLC. $32.1909/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722931 CMS
Aimmune Therapeutics, Inc. $21.9908/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954228373 CMS
GENZYME CORPORATION $26.3708/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938875269 CMS
GlaxoSmithKline, LLC. $14.2708/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722889 CMS
Teva Pharmaceuticals USA, Inc. $22.5708/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954740967 CMS
GlaxoSmithKline, LLC. $25.2608/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722869 CMS
Incyte Corporation $2.0008/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085623 CMS
Incyte Corporation $22.5208/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085625 CMS
Novartis Pharmaceuticals Corporation $19.5308/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893900223 CMS
kaleo, Inc. $25.5408/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941036443 CMS
Amgen Inc. $24.9408/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939474265 CMS
GENZYME CORPORATION $24.8608/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938875267 CMS
GENZYME CORPORATION $39.0708/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938875279 CMS
AstraZeneca Pharmaceuticals LP $18.1908/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915841875 CMS
AstraZeneca Pharmaceuticals LP $19.1808/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914926375 CMS
GlaxoSmithKline, LLC. $1.2307/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722947 CMS
GlaxoSmithKline, LLC. $7.9907/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944723007 CMS
Novartis Pharmaceuticals Corporation $30.7307/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893900219 CMS
Amgen Inc. $22.5607/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939474263 CMS
Incyte Corporation $15.0707/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085609 CMS
Incyte Corporation $4.2807/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085611 CMS
Incyte Corporation $1.6507/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943085613 CMS
GENZYME CORPORATION $24.9807/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938875249 CMS
GlaxoSmithKline, LLC. $0.7707/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722893 CMS
GlaxoSmithKline, LLC. $20.5707/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722983 CMS
AstraZeneca Pharmaceuticals LP $18.5707/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915718807 CMS
GlaxoSmithKline, LLC. $1.2507/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722877 CMS
GlaxoSmithKline, LLC. $9.4407/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722915 CMS
GlaxoSmithKline, LLC. $0.3907/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722953 CMS
GlaxoSmithKline, LLC. $1.9007/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722999 CMS
GlaxoSmithKline, LLC. $17.4607/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722979 CMS
Regeneron Healthcare Solutions, Inc. $26.5507/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927259711 CMS
kaleo, Inc. $22.3206/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941036439 CMS
GlaxoSmithKline, LLC. $22.1406/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944722919 CMS
AstraZeneca Pharmaceuticals LP $19.3806/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915851207 CMS
Amgen Inc. $22.9406/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939474261 CMS
Novartis Pharmaceuticals Corporation $24.7806/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893900215 CMS
ALK-Abello, Inc $22.4106/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 905017611 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,201.49 80
PY2020 $2,045.09 98
PY2021 $2,565.52 118
PY2022 $3,674.02 181
PY2023 $3,628.49 155
PY2024 $3,703.99 149
PY2025 $4,104.62 146

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $5,092.94 13
PY2024 Principal investigator $17,976.55 37
PY2023 Principal investigator $15,799.01 7
PY2022 Recipient $2,033.68 5
PY2022 Principal investigator $7,842.31 3
PY2021 Recipient $3,696.15 6
PY2021 Principal investigator $9,741.05 3
PY2020 Principal investigator $13,925.80 3
PY2019 Principal investigator $39,718.85 30

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 11/11/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184259305
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214946
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214948
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214950
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214952
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214954
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214956
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214958
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214960
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214962
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214964
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214966
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $372.94 07/02/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS CENTER
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184212427